Effect of preoperative portal venous thrombosis on liver transplantation for patients with end-stage liver cirrhosis
-
摘要:
目的 探讨术前门静脉血栓对终末期肝硬化患者行肝移植的影响。 方法 回顾性分析2007年1月至2011年12月在中山大学附属第三医院器官移植中心接受肝移植手术的182例终末期肝硬化患者的临床资料。将合并门静脉血栓的13例(Yerdel分级Ⅰ级3例, Ⅱ级6例, Ⅲ级2例, Ⅳ级2例)患者作为门静脉血栓组, 其余169例无门静脉血栓的患者作为对照组。比较两组患者肝移植术中和术后情况。 结果 与对照组比较, 门静脉血栓组的手术时间和术中出血量较多(均为P < 0.05), Ⅲ~Ⅳ级血栓者的手术时间和术中出血量亦较多(均为P < 0.05)。术后1个月, 门静脉血栓组发生门静脉血栓1例(8%), 对照组发生3例(2%), 两组比较差异有统计学意义(P < 0.05)。门静脉血栓组术后3年存活率为46%(6/13), 对照组相应为84%(142/169), 两组比较差异有统计学意义(P < 0.05)。 结论 Ⅲ~Ⅳ级门静脉血栓会明显增加肝移植手术难度和风险, 但只要术前严格评估门静脉血栓情况, 术中采用合理的门静脉重建方式, 依然可以取得良好的疗效。 Abstract:Objective To investigate the effect of preoperative portal venous thrombosis on liver transplantation for patients with end-stage liver cirrhosis. Methods Clinical data of 182 patients with end-stage liver cirrhosis undergoing liver transplantation at the Organ Transplantation Center of the Third Affiliated Hospital, Sun Yat-sen University from January 2007 to December 2011 were retrospectively studied. Thirteen patients complicated with portal venous thrombosis (3 patients were in Yerdel gradeⅠ, 6 were in grade Ⅱ, 2 were in grade Ⅲ and 2 were in grade Ⅳ) were divided into the portal venous thrombosis group. Other 169 patients without portal venous thrombosis were divided into the control group. The intra-operative and postoperative conditions of patients were compared between two groups. Results Compared with the control group, there were longer operation time, more intra-operative blood loss in the portal venous thrombosis group and the patient with Yerdel grade Ⅲ-Ⅳ. There was significant difference (both in P < 0.05). At one month after transplantation, one patient (8%) in the portal venous thrombosis group and three patients (2%) in the control group developed portal venous thrombosis, and there was significant difference (P < 0.05). Three-year survival rate of the portal venous thrombosis group was 46% (6/13) and that of the control group was 84% (142/169), and there was significant difference (P < 0.05). Conclusions Portal venous thrombosis of grade Ⅲ and Ⅳ may significantly increase the difficulty and risks of liver transplantation. However, the good curative effect may also be obtained only when the portal venous thrombosis is strictly assessed, and the rational portal venous reconstruction method is used during the operation. -
[1] Zhou GW. Treatment for portal venous complications after orthotopic liver transplantation and evaluation of long-term curative effect[J]. Organ Transplant, 2013, 4(6):335-338. https://www.ncbi.nlm.nih.gov/pubmed/16549187 [2] 周光文.原位肝移植术后门静脉并发症处理及远期疗效评估[J].器官移植, 2013, 4(6):335-338. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201306006.htmOtto G. Liver transplantation:an appraisal of the present situation[J]. Dig Dis, 2013, 31(1):164-169. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201306006.htm [3] Schuppan D, Afdhal NH. Liver cirrhosis[J]. Lancet, 2008, 371(9615):838-851. doi: 10.1016/S0140-6736(08)60383-9 [4] Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation:usefulness of screening and anticoagulation[J]. Gut, 2005, 54(5):691-697. doi: 10.1136/gut.2004.042796 [5] Garcia-Pagan JC, Valla DC. Portal vein thrombosis:a predictable milestone in cirrhosis?[J]. J Hepatol, 2009, 51(4):632-634. doi: 10.1016/j.jhep.2009.06.009 [6] 李洋.门静脉血栓与肝移植[J].器官移植, 2013, 4(3):165-168. http://www.cnki.com.cn/Article/CJFDTotal-QGYZ201303011.htmLi Y. Portal vein thrombosis and liver transplantation[J]. Organ Transplant, 2013, 4(3):165-168. http://www.cnki.com.cn/Article/CJFDTotal-QGYZ201303011.htm [7] Rodríguez-Castro KI, Porte RJ, Nadal E, et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation:a systematic review[J]. Transplantation, 2012, 94(11):1145-1153. doi: 10.1097/TP.0b013e31826e8e53 [8] Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(7):435-446. doi: 10.1038/nrgastro.2014.36 [9] Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51(4):682-689. doi: 10.1016/j.jhep.2009.03.013 [10] Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis:predictive factors and long-term outcomes[J]. Am J Gastroenterol, 2013, 108(4):568-574. doi: 10.1038/ajg.2012.452 [11] Ravaioli M, Zanello M, Grazi GL, et al. Portal vein thrombosis and liver transplantation:evolution during 10 years of experience at the University of Bologna[J]. Ann Surg, 2011, 253(2):378-384. doi: 10.1097/SLA.0b013e318206818b [12] Suarez Artacho G, Barrera Pulido L, Alamo Martinez JM, et al. Outcomes of liver transplantation in candidates with portal vein thrombosis[J]. Transplant Proc, 2010, 42(8):3156-3158. doi: 10.1016/j.transproceed.2010.05.057 [13] 陈国富, 范国华.脾切除术后门静脉系统血栓形成的临床分析[J].中国普外基础与临床杂志, 2012, 19(6):649-652. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htmChen GF, Fan GH. Clinical analysis of portal vein thrombosis after splenectomy[J]. Chin J Bases Clin Gen Surg, 2012, 19(6):649-652. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htm [14] 卢焕元, 黄飞舟, 聂晚频, 等.肝硬化门静脉高压症患者食管静脉曲张套扎术后复发再出血治疗方法的选择[J/CD].中华肝脏外科手术学电子杂志, 2012, 1(2):79-84. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htmLu HY, Huang FZ, Nie WP, et al. Treatment selection for hepatocirrhosis portal hypertension patients with recurrent hemorrhage after endoscopic variceal ligation[J/CD]. Chin J Hepat Surg: Electr Edit,2012,1(2):79-84. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL201206020.htm [15] 邹俊, 李学明, 陈海鸣, 等.门静脉高压症脾切除贲门周围血管离断术后门静脉血栓形成的相关因素分析[J].实用医学杂志, 2013, 29(4):581-583. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201304032.htmZou J, Li XM, Chen HM, et al. The related factors analysis on portal vein thrombosis after portal hypertension of splenectomy cardiac peripheral vascular[J]. J Pract Med, 2013, 29(4):581-583. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201304032.htm [16] Lai Q, Spoletini G, Pinheiro RS, et al. From portal to splanchnic venous thrombosis:what surgeons should bear in mind[J]. World J Hepatol, 2014, 6(8):549-558. https://www.ncbi.nlm.nih.gov/pubmed/25232448 [17] Paskonis M, Jurgaitis J, Mehrabi A, et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis:current role of cavoportal hemitransposition and renoportal anastomosis[J]. Clin Transplant, 2006, 20(5):551-562. doi: 10.1111/ctr.2006.20.issue-5 [18] Selvaggi G, Weppler D, Nishida S, et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis[J]. Am J Transplant, 2007, 7(2):454-460. doi: 10.1111/ajt.2007.7.issue-2 [19] Hibi T, Nishida S, Levi DM, et al. When and why portal vein thrombosis matters in liver transplantation:a critical audit of 174 cases[J]. Ann Surg, 2014, 259(4):760-766. doi: 10.1097/SLA.0000000000000252
点击查看大图
计量
- 文章访问数: 124
- HTML全文浏览量: 38
- PDF下载量: 11
- 被引次数: 0